soul trial oral semaglutide cardiovascular outcomes trial results Researchers to present CV findings from of in high-risk type 2 diabetes Oral Semaglutide and Cardiovascular Outcomes

Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: a pilot study

The one that works for you

Action steps: The goal of taking a weight loss medication is to become healthier

In general, when you lose weight quickly, it causes a sharp drop in muscle mass as well as fat, she says

Consult your provider if you experience severe or persistent nausea and vomiting that prevents adequate food or fluid intake, signs of pancreatitis including severe abdominal pain , vision changes or signs of diabetic retinopathy progression if you have diabetes, severe constipation lasting more than a week despite interventions, rapid heart rate or chest pain, or complete lack of appetite suppression or weight loss after reaching 1mg dose for at least four weeks

The typical picture on Wegovy is a diffuse, even thinning across the whole scalp